A Pediatric Case of Metastatic Conventional Parosteal Osteosarcoma Treated With Multidrug Chemotherapy

Pediatr Blood Cancer. 2016 Aug;63(8):1471-3. doi: 10.1002/pbc.26052. Epub 2016 May 3.

Abstract

Parosteal osteosarcoma (POS) is conventionally a low-grade sarcoma with limited metastatic potential; however, the tumor occasionally transforms into a high-grade dedifferentiated POS, which commonly metastasizes to distant organs. The present report describes a rare pediatric case of conventional POS with no dedifferentiated component yet had multiple pulmonary metastases at initial diagnosis. Following limb-sparing surgery and osteosarcoma-oriented neoadjuvant chemotherapy, the patient received total resection of pulmonary metastases. Despite no treatment for pulmonary recurrence 1 year after adjuvant chemotherapy, the patient is alive with stable disease 4 years and 6 months after the initial diagnosis.

Keywords: chemotherapy; cyclin-dependent kinase 4; metastasis; parosteal osteosarcoma; pediatric.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / diagnostic imaging
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / pathology*
  • Child
  • Cisplatin / therapeutic use
  • Disease-Free Survival
  • Doxorubicin / therapeutic use
  • Humans
  • Ifosfamide / therapeutic use
  • Lung Neoplasms / pathology
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / surgery
  • Male
  • Methotrexate / therapeutic use
  • Osteosarcoma, Juxtacortical / diagnostic imaging
  • Osteosarcoma, Juxtacortical / drug therapy*
  • Osteosarcoma, Juxtacortical / pathology*
  • Periosteum / pathology*
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Doxorubicin
  • Cisplatin
  • Ifosfamide
  • Methotrexate